FWIW some diagnostics winners absolutely print money on their offerings, and today I'd put EXAS among them - that company is managed to basically spend everything on growth/development and a large infrastructure for both, which could prove a high ROI or not. It could be producing its current revenue with far lower expenses if they had gone for that course.
News 
Market Data 
Discover 
